Abstract
All aspects of prostate cancer evolution are closely related to androgen levels and the status of the androgen receptor (AR). Almost all treatments target androgen metabolism pathways and AR, from castration-sensitive prostate cancer (CSPC) to castration-resistant prostate cancer (CRPC). Alterations in androgen metabolism and its response are one of the main reasons for prostate cancer drug resistance. In this review, we will introduce androgen metabolism, including how the androgen was synthesized, consumed, and responded to in healthy people and prostate cancer patients, and discuss how these alterations in androgen metabolism contribute to the resistance to anti-androgen therapy.
Funding Information
  • National Natural Science Foundation of China (82173131, JCYJ20210324104007022)
  • Science and Technology Innovation Commission of Shenzhen Municipal Government Grand (82173131, JCYJ20210324104007022)

This publication has 107 references indexed in Scilit: